http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114424064-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0018646533b3a43ff37e0c674b5646a0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2033-4975 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-4972 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-082 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2020-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c366ad7f1ab095feb04e14a047faec9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6332b6ca5d0b1acd759cfee7a4472b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17291712b6aeacd0075de945b55be209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_267fd078473a335347347a064f43e4b5 |
| publicationDate | 2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114424064-A |
| titleOfInvention | Biomarker Detection |
| abstract | The present invention relates to a method for diagnosing a subject suffering from cancer or a susceptibility to cancer. The method comprises detecting in a bodily sample from a test subject at least one carbohydrate and/or at least one amino acid or precursor thereof and/or at least one polynucleotide present in a composition previously administered to the subject Concentrations of characteristic compounds produced by the metabolism of alcohols. The sugar is present in the composition at a concentration of greater than 20,000 mg/100 ml, the amino acid or precursor thereof is present in the composition at a concentration of at least 500 mg/ml, and the polyol is present in the composition at a concentration of greater than 25,000 mg/100 ml. The method also includes comparing the concentration to a reference for the concentration of the characteristic compound in the individual without cancer. In particular, an increase or decrease in the concentration of the characteristic compound compared to a reference indicates that the subject has cancer, or has a susceptibility to cancer, or provides a negative prognosis for the subject's condition. |
| priorityDate | 2019-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 229.